Prospective Monitoring of Epstein-Barr Virus DNA in Adult Renal Transplant Recipients During the Early Posttransplant Period: Role of Mycophenolate Mofetil-Reference-Cited by-同舟云学术

Prospective Monitoring of Epstein-Barr Virus DNA in Adult Renal Transplant Recipients During the Early Posttransplant Period: Role of Mycophenolate Mofetil

Published:2009-03-27 Issue:6 Volume:87 Page:852-856
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Holmes Michael V.,Caplin Ben,Atkinson Claire,Smith Colette,Harber Mark,Sweny Paul,Haque Tanzina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference23 articles.

1. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.;Khanna;Annu Rev Microbiol,2000

2. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.;Burns;Blood Rev,2004

3. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).;Nalesnik;Springer Semin Immunopathol,1998

4. Lymphomas after solid organ transplantation: A collaborative transplant study report.;Opelz;Am J Transplant,2004

5. Prompt versus preemptive intervention for EBV lymphoproliferative disease.;Wagner;Blood,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and Management of PTLD;Transplantation;2023-10-21

2. Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function;Frontiers in Immunology;2023-07-03

3. Risk factors for post‐transplant Epstein‐Barr virus events in pediatric recipients of hematopoietic stem cell transplants;Pediatric Transplantation;2021-06-02

4. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19;Journal of Autoimmunity;2020-07

5. Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+T cells activities after hematopoietic transplantation for blood malignancies;Journal for ImmunoTherapy of Cancer;2020-03